11β-substituted 13β-ethyl gonane derivatives exhibit reversal of antiprogestational activity

Steroids

Volumn 63, Issue 1, 1998, Pages 50-57

  Rao, Pemmaraju N ^a   Cessac, James W ^a   Blye, Richard P ^b   Kim, Hyun K ^b  

^a SW Found for Biomedical Research ^*  (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

13 ethyl gonane derivatives; Antiprogestin; CDB 2914; Progestin; Synthesis

Indexed keywords

17ALPHA ACETOXY 11BETA (4 DIMETHYLAMINOPHENYL) 19 NORPREGNA 4,9 DIENE 3,20 DIONE; 17ALPHA ACETOXY 13BETA ETHYL 11BETA (4 ACETYLPHENYL) 18,19 DINORPREGNA 4,9 DIENE 3,20 DIONE; 17ALPHA ACETOXY 13BETA ETHYL 11BETA [4 (METHYLTHIOPHENYL)] 18,19 DINORPREGNA 4,9 DIENE 3,20 DIONE; 17ALPHA ACETOXY 13BETA ETHYL 11BETA [4 (N,N DIMETHYLAMINO)PHENYL] 18,19 DINORPREGNA 4,9 DIENE 3,20 DIONE; ANTIGESTAGEN; LEVONORGESTREL; MIFEPRISTONE; NORETHISTERONE; NORGESTREL; PROGESTERONE RECEPTOR; RU 43855; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; HORMONE INHIBITION; NONHUMAN; RABBIT; THYMUS;

ANIMALS; BIOLOGICAL ASSAY; FEMALE; GONANES; HORMONE ANTAGONISTS; LEVONORGESTREL; MIFEPRISTONE; NORPREGNADIENES; PROGESTINS; RABBITS; RECEPTORS, GLUCOCORTICOID; RECEPTORS, PROGESTERONE;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0031963453     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(97)00119-0     Document Type: Article

References (26)

1. Teutsch G. Agarwal MK. Adrenal Steroid Antagonism. 1984;43-75 Walter de Gruyter and Co, Berlin.
2. Nieman LK, Chrousos GP, Kellner C, Spitz IM, Nisula BC, Cutler GB, Merriam GR, Bardin CW, Loriaux DL. Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab. 61:1985;536-540.
3. Cook CE, Lee Y-W, Wani MC, Fail PA, Petrow V. Effect of D-ring substituents on antiprogestational (antagonist) and progestational (agonist) activity of 11β-aryl steroids. Human Reprod. 9:1994;32-39.
4. Moguilewsky M, Deraedt R. Interactions between glucocorticoid and progestin receptors. J Steroid Biochem. 15:1981;329-335.
5. Klimstra PD, Colton FB. The chemistry of steroidal contraceptives. Lednicer D. Contraception The Chemical Control of Fertility . 1969;69-159 Marcel Dekker Inc, New York.
6. Teutsch G, Philibert D. History and perspectives of antiprogestins from the chemist's point of view. Human Reprod. 9:1994;12-31.
7. Detty MR, Murray BJ, Smith DL, Zumbulyadis N. Cyclization of 3-(Arylchalcogeno)propenoyl Chlorides. 1. 1,2-Oxatelluro-1-ium Halides via "Ipso" Acylation. J Am Chem Soc. 105:1983;875-882.
8. Joly R, Warnanat J, Joly J. 3-Methyl-3-alkoxy-4-oxagona-5(10),9(11)-dienes. Fr., 1526961 680531; CA 73:15102.
9. McGinty DA, Anderson LP, McCollough NB. Effect of local application of progesterone on the rabbit uterus. Endocrinology. 24:1939;829-832.
10. Clauberg C. Zur Physiologie und Pathologie der Sexualhormone, im besonderen Hormones des Corpus luteum. Zentralbl Gynakol. 54:1930;2757-2770.
11. McPhail MK. The assays of progestin. J Physiol. 83:1934;145-156.
12. Bliss CI. The Statistics of Bioassay. 1952;Academic Press, New York.
13. Hollister C. Prophet - A national computing resource for life science research. Nuc Acids Res. 16:1988;1873-1875.
14. Holford N. Drugmodel-Prophet Public Procedures. 1990;BBN System and Technologies, Cambridge, MA.
15. Perry HM (1992). Prophet statistical and programming consultant under Contract No. NO1-RR-2103.
16. 4,9-3-ketosteroids . J Am Chem Soc. 82:1960;2402-2403.
17. Hofmeister H, Annen K, Laurent H, Wiechert R. Process for the preparation of pregnane derivatives. US Patent 4102908.
18. Belanger A, Philibert D, Teutsch G. Regio and stereospecific synthesis of 11β-substituted 19-nor-steroids Influence of 11β-substitution on progesterone receptor affinity . Steroids. 37:1981;361-382.
19. Teutsch G, Klich M, Bouchoux F, Cerede E, Philibert D. Synthesis of a fluorescent steroid derivative with high affinities for the glucocorticoid and progesterone receptors. Steroids. 59:1994;22-26.
20. Carruthers NI, Garshasb S. Synthesis of corticoids from 9α-hydroxyandrost-4-ene-3,17-dione. J Org Chem. 57:1992;961-965.
21. Cook CE, Wani MC, Lee Y-W, Fail PA, Petrow V. Reversal of activity profile in analogs of the antiprogestin RU 486 Effect of a 16α-substituent on progestational (agonist) activity . Life Sci. 12:1992;155-162.
22. Teutsch G. Analogs of RU486 for the mapping of progestin receptor Synthetic and structural aspects . Baulieu EE, Segal SJ. The Antiprogestational Steroid RU486 and Human Fertility. 1985;27-47 Plenum Press, New York.
23. Teutsch G, Gaillard-Moguilewsky M, Lemoine G, Nique F, Philibert D. Design of ligands for the glucocorticoid and progestin receptors. Biochem Soc Trans. 19:1991;901-908.
24. Klebe G, Abraham U, Mietzner T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem. 37:1994;4130-4146.
25. Cramer RD III, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc. 110:1988;5959-5967.
26. Loughney DA, Schwender CF. A comparison of progestin and androgen receptor binding using the CoMFA technique. J Comput-Aided Mol Des. 6:1992;569-581.